➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Express Scripts
Baxter
McKinsey
Merck

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Lutetium dotatate lu-177 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lutetium dotatate lu-177 and what is the scope of patent protection?

Lutetium dotatate lu-177 is the generic ingredient in one branded drug marketed by Aaa Usa Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lutetium dotatate lu-177 has seven patent family members in four countries.

There are four drug master file entries for lutetium dotatate lu-177. One supplier is listed for this compound.

Recent Clinical Trials for lutetium dotatate lu-177

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
Progenics Pharmaceuticals, Inc.Phase 1/Phase 2
National Cancer Institute (NCI)Phase 1/Phase 2

See all lutetium dotatate lu-177 clinical trials

US Patents and Regulatory Information for lutetium dotatate lu-177

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;INTRAVENOUS 208700-001 Jan 26, 2018 RX Yes Yes   Get Started Free   Get Started Free Y   Get Started Free
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;INTRAVENOUS 208700-001 Jan 26, 2018 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;INTRAVENOUS 208700-001 Jan 26, 2018 RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;INTRAVENOUS 208700-001 Jan 26, 2018 RX Yes Yes   Get Started Free   Get Started Free Y   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for lutetium dotatate lu-177

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2020021465   Get Started Free
Singapore 11202100645X   Get Started Free
World Intellectual Property Organization (WIPO) 2020064693   Get Started Free
Taiwan 202019489   Get Started Free
World Intellectual Property Organization (WIPO) 2020021310   Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Moodys
Merck
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.